118 related articles for article (PubMed ID: 12458767)
41. Aldose reductase inhibition of a saponin-rich fraction and new furostanol saponin derivatives from Balanites aegyptiaca.
Abdel Motaal A; El-Askary H; Crockett S; Kunert O; Sakr B; Shaker S; Grigore A; Albulescu R; Bauer R
Phytomedicine; 2015 Aug; 22(9):829-36. PubMed ID: 26220630
[TBL] [Abstract][Full Text] [Related]
42. Bioassay-guided identification of an anti-inflammatory prenylated acylphloroglucinol from Melicope ptelefolia and molecular insights into its interaction with 5-lipoxygenase.
Shaari K; Suppaiah V; Wai LK; Stanslas J; Tejo BA; Israf DA; Abas F; Ismail IS; Shuaib NH; Zareen S; Lajis NH
Bioorg Med Chem; 2011 Nov; 19(21):6340-7. PubMed ID: 21958738
[TBL] [Abstract][Full Text] [Related]
43. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
Bhadada SV; Vyas VK; Goyal RK
Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
[TBL] [Abstract][Full Text] [Related]
44. Identification of new potent inhibitor of aldose reductase from Ocimum basilicum.
Bhatti HA; Tehseen Y; Maryam K; Uroos M; Siddiqui BS; Hameed A; Iqbal J
Bioorg Chem; 2017 Dec; 75():62-70. PubMed ID: 28917123
[TBL] [Abstract][Full Text] [Related]
45. Production of biologically active oxidized derivatives of finasteride through metabolism by Aspergillus niger culture.
Ali S; Nisar M; Shah Z
Pharm Biol; 2016 Nov; 54(11):2771-2776. PubMed ID: 27181333
[TBL] [Abstract][Full Text] [Related]
46. Inhibitory effects of isorhamnetin-3-O-beta-D-glucoside from Salicornia herbacea on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Lee YS; Lee S; Lee HS; Kim BK; Ohuchi K; Shin KH
Biol Pharm Bull; 2005 May; 28(5):916-8. PubMed ID: 15863906
[TBL] [Abstract][Full Text] [Related]
47. A flavone from Manilkara indica as a specific inhibitor against aldose reductase in vitro.
Haraguchi H; Hayashi R; Ishizu T; Yagi A
Planta Med; 2003 Sep; 69(9):853-5. PubMed ID: 14598214
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
49. Aldose reductase inhibitors from Viola hondoensis W. Becker et H Boss.
Chung IM; Kim MY; Park WH; Moon HI
Am J Chin Med; 2008; 36(4):799-803. PubMed ID: 18711775
[TBL] [Abstract][Full Text] [Related]
50. Antioxidant capacity and DNA-interaction studies of zinc complexes with a non-steroidal anti-inflammatory drug, mefenamic acid.
Tarushi A; Karaflou Z; Kljun J; Turel I; Psomas G; Papadopoulos AN; Kessissoglou DP
J Inorg Biochem; 2013 Nov; 128():85-96. PubMed ID: 23948577
[TBL] [Abstract][Full Text] [Related]
51. Aldose reductase inhibitors from Litchi chinensis Sonn.
Lee SJ; Park WH; Park SD; Moon HI
J Enzyme Inhib Med Chem; 2009 Aug; 24(4):957-9. PubMed ID: 19555177
[TBL] [Abstract][Full Text] [Related]
52. Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts.
Lee EH; Song DG; Lee JY; Pan CH; Um BH; Jung SH
Biol Pharm Bull; 2008 Aug; 31(8):1626-30. PubMed ID: 18670102
[TBL] [Abstract][Full Text] [Related]
53. Flavonoids, gallotannins and ellagitannins in Syzygium guineense and the traditional use among Malian healers.
Nguyen TL; Rusten A; Bugge MS; Malterud KE; Diallo D; Paulsen BS; Wangensteen H
J Ethnopharmacol; 2016 Nov; 192():450-458. PubMed ID: 27647014
[TBL] [Abstract][Full Text] [Related]
54. Aldose reductase inhibitory constituents of the root of Salvia miltiorhiza Bunge.
Tezuka Y; Kasimu R; Basnet P; Namba T; Kadota S
Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1306-11. PubMed ID: 9377780
[TBL] [Abstract][Full Text] [Related]
55. 20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng.
Fatmawati S; Ersam T; Yu H; Zhang C; Jin F; Shimizu K
Bioorg Med Chem Lett; 2014 Sep; 24(18):4407-4409. PubMed ID: 25152999
[TBL] [Abstract][Full Text] [Related]
56. Curcumin analogs as potent aldose reductase inhibitors.
Du ZY; Bao YD; Liu Z; Qiao W; Ma L; Huang ZS; Gu LQ; Chan AS
Arch Pharm (Weinheim); 2006 Mar; 339(3):123-8. PubMed ID: 16528793
[TBL] [Abstract][Full Text] [Related]
57. YUA001, a novel aldose reductase inhibitor isolated from alkalophilic Corynebacterium sp. YUA25. I. Taxonomy, fermentation, isolation and characterization.
Bahn Y; Park J; Bai D; Takase S; Yu J
J Antibiot (Tokyo); 1998 Oct; 51(10):902-7. PubMed ID: 9917002
[TBL] [Abstract][Full Text] [Related]
58. Inhibitory activities of the alkaloids from Coptidis Rhizoma against aldose reductase.
Jung HA; Yoon NY; Bae HJ; Min BS; Choi JS
Arch Pharm Res; 2008 Nov; 31(11):1405-12. PubMed ID: 19023536
[TBL] [Abstract][Full Text] [Related]
59. CJ-21,164, a new D-glucose-6-phosphate phosphohydrolase inhibitor produced by a fungus Chloridium sp.
Kim YJ; Nishida H; Pang CH; Saito T; Sakemi S; Tonai-Kachi H; Yoshikawa N; Vanvolkenburg MA; Parker JC; Kojima Y
J Antibiot (Tokyo); 2002 Feb; 55(2):121-7. PubMed ID: 12002992
[TBL] [Abstract][Full Text] [Related]
60. Nafuredin, a novel inhibitor of NADH-fumarate reductase, produced by Aspergillus niger FT-0554.
Ui H; Shiomi K; Yamaguchi Y; Masuma R; Nagamitsu T; Takano D; Sunazuka T; Namikoshi M; Omura S
J Antibiot (Tokyo); 2001 Mar; 54(3):234-8. PubMed ID: 11372780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
